US equity
·Updated Oct 12, 21:38 UTCBSX
Boston Scientific Corporation
Health Care·Large cap·$65.2B
43.84
+2.6% today
No price history available for this name yet.
Returns & momentum
1D+2.6%
1W+3.4%
1M+2.0%
3M+2.8%
6M-30.6%
1Y-54.9%
YTD—
All-time—
Range & moving averages
Price43.84
52w high-58.5%
52w low+5.9%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume13.6M
Turnover$596M
Market cap$65.2B
RVOL0.69×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B | $9.9B | $10.7B | $9.8B | $9.0B | $8.4B | $7.5B | $7.5B | $7.1B | $7.0B | $7.6B | $8.2B |
| Cost of revenue | $6.2B | $5.3B | $4.3B | $4.0B | $3.7B | $3.5B | $3.1B | $2.8B | $2.6B | $2.4B | $2.2B | $2.2B | $2.2B | $2.3B | $2.7B | $2.6B |
| Gross profit | $13.9B | $11.5B | $9.9B | $8.7B | $8.2B | $6.4B | $7.6B | $7.0B | $6.5B | $6.0B | $5.3B | $5.2B | $5.0B | $4.9B | $5.0B | $5.6B |
| Selling, general & admin | $6.9B | $6.0B | $5.2B | $4.5B | $4.4B | $3.8B | $3.9B | $3.6B | $3.3B | $3.1B | $2.9B | $2.9B | $2.7B | $2.5B | $2.5B | $2.6B |
| Operating expenses | $10.2B | $8.9B | $7.6B | $7.1B | $7.0B | $6.5B | $6.1B | $5.5B | $5.2B | $5.5B | $5.6B | $5.5B | $4.8B | $8.8B | $4.1B | $6.5B |
| Operating income | $3.6B | $2.6B | $2.3B | $1.6B | $1.2B | -$80M | $1.5B | $1.5B | $1.3B | $447M | -$283M | -$301M | $120M | -$3.9B | $904M | -$894M |
| Interest expense | $349M | $305M | $265M | $470M | $341M | $361M | $473M | $241M | $229M | $233M | $284M | $216M | $324M | $261M | $281M | $407M |
| Income tax | $493M | $436M | $393M | $443M | $36M | $2M | -$4.0B | -$249M | $828M | -$170M | -$411M | -$390M | -$102M | -$39M | $201M | -$283M |
| EPS — basic | $1.96 | $1.26 | $1.08 | $0.45 | $0.69 | -$0.08 | $3.38 | $1.21 | $0.08 | $0.26 | -$0.18 | -$0.09 | -$0.09 | -$2.89 | $0.29 | -$0.68 |
| EPS — diluted | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | -$0.08 | $3.33 | $1.19 | $0.08 | $0.25 | -$0.18 | -$0.09 | -$0.09 | -$2.89 | $0.29 | -$0.68 |
| Shares — basic | 1.48B | 1.47B | 1.45B | 1.43B | 1.42B | 1.42B | 1.39B | 1.38B | 1.37B | 1.36B | 1.34B | 1.32B | 1.34B | 1.41B | 1.51B | 1.51B |
| Shares — diluted | 1.49B | 1.49B | 1.46B | 1.44B | 1.43B | 1.42B | 1.41B | 1.4B | 1.39B | 1.38B | 1.34B | 1.32B | 1.34B | 1.41B | 1.52B | 1.51B |
From SEC filings (public domain), since 2008. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.